跳至主要内容
临床试验/NCT05455125
NCT05455125Unknown不适用

A Cardiac Sub-Study of the MRC National Survey of Health and Development (NSHD)

University College, London1 个研究点 分布在 1 个国家目标入组 550 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
550
试验地点
1
主要终点
CMR phenotype - Aortic blood flow

研究概览

简要总结

Background The life course accumulation of overt and subclinical myocardial dysfunction contributes to older age mortality, frailty, disability and loss of independence. The Medical Research Council National Survey of Health and Development (NSHD) is the world's longest running continued surveillance birth cohort providing a unique opportunity to understand life course determinants of myocardial dysfunction as part of MyoFit46-the cardiac sub-study of the NSHD.

Methods and expected results The investigators aim to recruit 550 NSHD participants of approximately 75 years+ to undertake high-density surface electrocardiographic imaging (ECGI) and stress perfusion cardiovascular magnetic resonance (CMR). Through comprehensive myocardial tissue characterization and 4-dimensional flow the investigators hope to better understand the burden of clinical and subclinical cardiovascular disease. Supercomputers will be used to combine the multi-scale ECGI and CMR datasets per participant. Rarely available, prospectively collected whole-of-life data on exposures, traditional risk factors and multimorbidity will be studied to identify risk trajectories, critical change periods, mediators and cumulative impacts on the myocardium.

Conclusion By combining well curated, prospectively acquired longitudinal data of the NSHD with novel CMR-ECGI data and sharing these results and associated pipelines with the CMR community, MyoFit46 seeks to transform our understanding of how early, mid and later-life risk factor trajectories interact to determine the state of cardiovascular health in older age.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • NSHD study member.
  • Who is still alive and agreed to take part in the study.

排除标准

  • Pacemaker.
  • Implantable cardio defibrillator.
  • Atrial fibrillation.
  • Complete heart block.
  • Severe asthma.

结局指标

主要结局

CMR phenotype - Aortic blood flow

时间窗: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

CMR phenotype - Myocardial blood flow

时间窗: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

CMR phenotype - T1

时间窗: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

CMR phenotype - T2

时间窗: Through study completion, an average of 4 years.

This will be assessed through a 45 minute cardiac MRI scan with perfusion.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验